As a leading contract development and manufacturing organization (CDMO), Evonik offers the confidence and expertise you need to tackle complex drug development and manufacturing challenges. Partnering with us means gaining access to a global network of services and deep technical know-how.
Evonik is one of the world’s largest CDMOs, with core strengths in chemistry, engineering, and biotechnology. Our proven track record is built on quality, supply security, and a strong commitment to sustainability. With our business-for-business (B4B) philosophy, we focus on shared success—supporting companies of all sizes through purposeful collaboration and a commitment to long-term partnerships.
For over 20 years, Evonik has supported customers with innovator-focused HPAPI projects and complex API processes. Our robust manufacturing network delivers APIs, HPAPIs, and intermediates—from clinical trial quantities to large-scale commercial volumes. Whether your project is small or highly complex, we offer reliable, high-quality production with a sustainable supply chain.
Evonik’s Western-based facilities are designed for complex pharmaceutical manufacturing, offering:
Our scalable and sustainable solutions ensure high-quality drug substance development and reliable contract manufacturing for complex APIs.
Evonik provides safe and compliant manufacturing of highly potent APIs, supported by:
We help pharmaceutical partners meet regulatory standards and respond to growing demand for HPAPI contract manufacturing.
Evonik specializes in scheduled drug manufacturing, offering:
With advanced containment and strong regulatory experience, we ensure secure and compliant API supply for controlled substances.
We supply GMP-grade PEG and mPEG for PEGylation and linker conjugation, featuring:
Our products support optimized synthesis following all regulatory standards.
We offer a highly differentiated portfolio of technologies to support even the most complex syntheses of APIs, HPAPIs, and intermediates. Our flexible solutions span the entire development lifecycle—from early-stage process development to full-scale commercial manufacturing.
Leveraging deep expertise in chemical innovation and advanced engineering, we tailor our approach to meet specialized requirements with precision, safety, and scalability.
Our integrated capabilities include:
Our technologies are designed to meet the growing demand for efficient, safe, and sustainable manufacturing of high-potency and complex molecules. Through continuous investment in state-of-the-art facilities and novel process technologies, we empower pharmaceutical innovators to advance their pipelines with confidence and agility.
At Evonik, sustainability is embedded in how we support our customers—by enabling the development of effective therapies while minimizing environmental impact.
We apply sustainable practices across the entire pharmaceutical lifecycle—from lab to large-scale production. Our tailored approaches include:
Our commitment to sustainability drives smarter, safer, and more efficient pharmaceutical manufacturing.
Our sites in Europe, the U.S. and China have capacities from lab-scale through to small, medium or large-scale production:
Take the first step to tackling your complex drug development and manufacturing challenges. Get in touch!
"Exploring options for the development and manufacture of your cGMP small molecule drug substance or associated intermediates? Reach out and we'll help you make well informed choices as Evonik aims at getting clients practical solutions faster and easier."
Eric Neuffer
Head of Drug Substance Sales
